Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Neural Intervention Technologies

2003 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of novel liquid embolic material intended for the treatment of blood vessel defects. The company develops embolization products that are non-adhesive, non-toxic, and have tissue-like mechanical and biocompatible properties, and are used to treat aneurysms, arteriovenous malformations (AVMs), and tumors.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Acquirer
W. L. Gore and Associates
Primary Office
  • 3985 Research Park Drive
  • Suite 3
  • Ann Arbor, MI 48108
  • United States

Neural Intervention Technologies Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Neural Intervention Technologies‘s full profile, request access.

Request full access to PitchBook

Neural Intervention Technologies Executive Team (3)

Name Title Board
Seat
Contact
Info
Houng-Yau Mei Chief Executive Officer
Timothy Becker Chief Technology Officer & Co-Founder
Daryl Kipke Ph.D Co-Founder